Title : Ruxolitinib - better prognostic impact in low-intermediate 1 risk score: evaluation of the 'rete ematologica pugliese' (REP) in primary and secondary myelofibrosis.

Pub. Date : 2017 Jan

PMID : 27263544






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 In conclusion, ruxolitinib is effective, with a better outcome in patients with a low-int1 risk score. ruxolitinib Wnt family member 1 Homo sapiens